A detailed history of Colonial Trust Advisors transactions in Novo Nordisk A S stock. As of the latest transaction made, Colonial Trust Advisors holds 550 shares of NVO stock, worth $48,053. This represents 0.01% of its overall portfolio holdings.

Number of Shares
550
Previous 550 -0.0%
Holding current value
$48,053
Previous $78,000 16.67%
% of portfolio
0.01%
Previous 0.01%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$122.71 - $146.91 $490 - $587
4 Added 0.73%
550 $78,000
Q1 2024

May 13, 2024

BUY
$102.11 - $135.92 $9,802 - $13,048
96 Added 21.33%
546 $70,000
Q3 2023

Nov 13, 2023

BUY
$90.94 - $199.54 $20,461 - $44,896
225 Added 100.0%
450 $40,000
Q4 2022

Feb 14, 2023

BUY
$102.55 - $135.33 $23,073 - $30,449
225 New
225 $30,000

Others Institutions Holding NVO

About NOVO NORDISK A S


  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $197B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track Colonial Trust Advisors Portfolio

Follow Colonial Trust Advisors and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Colonial Trust Advisors, based on Form 13F filings with the SEC.

News

Stay updated on Colonial Trust Advisors with notifications on news.